ENLV·M4130Y106·US·equity·Healthcare - Biotechnology-13D/G
ENLV (ENLIVEX LTD) is held by 23 institutional investors as of Q1 2026. Largest holders: ARK Investment Management LLC ($584,391), TWO SIGMA INVESTMENTS, LP ($136,178), UBS Group AG ($128,646). Net institutional sentiment: Mixed.
See how ENLV's score breaks down across 4 SEC sources
Showing 1-20 of 25
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer